Clinical trial
Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn
NCT03007381 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- November 30, 2017
- Completion date
- June 30, 2019
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer female